Cancer care is changing rapidly, and no area is changing faster than complex malignant hematology. Complex Malignant Hematology is a comprehensive course covering core competency areas in managing hematological malignancies. This course is designed to equip you with the knowledge you need to succeed in this challenging yet rewarding subspecialty.

The course is divided into twelve sections with forty-six modules in total. The first section is an optional review of hematopoiesis, the immune system and diagnostic testing. The next four sections will introduce you to the essentials of multiple myeloma, lymphoma, leukemia, and aplastic anemia. These four disease-site sections cover pathophysiology, incidence, risk factors, clinical presentation, and more importantly, the latest updates in diagnostics, staging, and treatment options. The disease site sections are followed by a focused section on hematopoietic stem cell transplant and adoptive cell therapy that includes the latest indications and possible complications. The latter half of the course will introduce you to the complications of hematological malignancies and their treatment, with a focus on anticipating and preventing oncological emergencies. The final two sections explore psychosocial issues for patients and families, and survivorship care.

Course Syllabus

Course Objectives

Upon completion of this course, participants will be able to:

• Describe the clinical presentation, risk factors, and pathophysiology of multiple myeloma, lymphoma, leukemia, and aplastic anemia.
• Explain the diagnosis and staging of each disease site, including prognostic indicators where available.
• Identify treatment modalities that are currently used for each site.
• Differentiate the care needs of patients receiving allogenic and autologous hematopoietic stem cell transplant, CAR T-cell therapy, and bi-specific T-cell engagers.
• Identify complications of the disease or its treatment and explain the assessment and management of these complications.
• Anticipate, prevent, and manage oncological emergencies seen in patients with hematological cancers.
• Identify the components to be integrated into patient and family education based on diagnosis, treatment, prognosis, and potential complications.
• Recognize the unique survivorship issues people with hematological malignancies experience.

Course Requirements

To receive a certificate and a 1.0 credit toward Treatment and Delivery of Evidence Based Care, participants must complete the following before the course completion date:

1. Complete a pre-course evaluation
2. Complete all course modules
3. Pass all four section tests successfully (See passing grade for each section test in the syllabus)  
4. Complete a post-course evaluation

Time Commitment: This is a self-paced course. Participants can start at any time and have 20 weeks to complete all the course requirements. Upon successful completion, participants will be awarded a certificate for 40 learning hours.

Full Course Syllabus: View the course syllabus

Eligibility

To enroll in the course, participants must be Nurses, Physician Assistants, Physicians, or Pharmacists.

Funding Opportunities: Please click HERE for more details.

Group pricing is available when you have 3 or more courses or participants. Click HERE for more details.

Payment must be received before you have access to the course. For more information, please visit our Cancellation & No Show Policy.

Participants can pay for this course online with a credit card, or send a cheque to: